Colossal Recieves Series C Funding

Colossal Biosciences, the world’s first de-extinction company, announced today that it has secured Series C funding led by TWG Global, a diversified holding company co-founded by Mark Walter and Thomas Tull, with investments spanning technology/AI, financial services, private lending, and sports and media.

The new funding will enable Colossal to further develop its cutting-edge genetic engineering technologies and pioneer innovative software, wetware, and hardware solutions. These advancements extend beyond de-extinction, offering applications in species preservation and human healthcare.

Learn more